Your browser doesn't support javascript.
loading
Cost-Benefit Assessment of the Electronic Health Records for Clinical Research (EHR4CR) European Project.
Beresniak, A; Schmidt, A; Proeve, J; Bolanos, E; Patel, N; Ammour, N; Sundgren, M; Ericson, M; De Moor, G; Kalra, D; Dupont, D.
Affiliation
  • Beresniak A; Data Mining International, Geneva, Switzerland.
  • Schmidt A; F Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Proeve J; Bayer Healthcare, Leverkusen, Germany.
  • Bolanos E; Eli Lilly and Company, Alcobendas, Spain.
  • Patel N; Eli Lilly and Company (until December 2013), Windlesham, Surrey, UK.
  • Ammour N; Sanofi-Aventis R&D, Chilly-Mazarin, France.
  • Sundgren M; AstraZeneca, Mölndal, Sweden.
  • Ericson M; Amgen, Neuilly-sur-Seine, France.
  • De Moor G; University of Ghent, Ghent, Belgium.
  • Kalra D; The European Institute for Health Records (EuroRec), London, UK.
  • Dupont D; Data Mining International, Geneva, Switzerland.
Value Health ; 17(7): A630, 2014 Nov.
Article in En | MEDLINE | ID: mdl-27202235
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Year: 2014 Document type: Article